If you experience a minor headache or discomfort, over-the-counter pain relievers can be effective, but its best to use them under a doctor's guidance

Here's how they compare: Semaglutide (GLP-1 agonist) Mechanism: Single-action GLP-1 receptor agonist FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: 15-20% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients starting their weight loss journey seeking proven, well-studied medication Tirzepatide (dual GIP/GLP-1 agonist) Mechanism: Targets both GIP and GLP-1 receptors for enhanced metabolic effect FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: Up to 22% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients seeking more aggressive fat loss with dual-action metabolic support Retatrutide (triple agonist, not yet available) Mechanism: Targets GLP-1, GIP, and glucagon receptors FDA status: Not FDA-approved

[DOI] [PMC free article] [PubMed] [Google Scholar] [7].Arnold SV, Kosiborod M, Wang J, Fenici P, Gannedahl G, LoCasale RJ, Diabetes, Obesity and Metabolism 2018, 20, 2000
23 Guenoun et al
The cold numbs the surface nerve endings, making needle entry virtually painless